A detailed history of Strata Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Strata Wealth Advisors, LLC holds 1,644 shares of ABBV stock, worth $384,696. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,644
Previous 1,369 20.09%
Holding current value
$384,696
Previous $254 Million 49.8%
% of portfolio
0.1%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$184.85 - $231.54 $50,833 - $63,673
275 Added 20.09%
1,644 $381 Million
Q2 2025

Jul 30, 2025

BUY
$170.16 - $206.27 $26,204 - $31,765
154 Added 12.67%
1,369 $254 Million
Q1 2025

May 01, 2025

SELL
$169.2 - $216.66 $49,914 - $63,914
-295 Reduced 19.54%
1,215 $255 Million
Q4 2024

Jan 31, 2025

BUY
$164.99 - $203.87 $249,134 - $307,843
1,510 New
1,510 $268 Million
Q1 2024

Apr 17, 2024

BUY
$159.82 - $182.1 $369,983 - $421,561
2,315 New
2,315 $422 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Strata Wealth Advisors, LLC Portfolio

Follow Strata Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strata Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strata Wealth Advisors, LLC with notifications on news.